REQUEST A DEMO
Total
USD $0.00
Search more companies

Essepharm S. R. O. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Direct Selling Establishments | General Warehousing and Storage | Research and Development in Nanotechnology | All Other Business Support Services | All Other Ambulatory Health Care Services
Full name: Essepharm S. R. O. Profile Updated: July 29, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Essepharm S. R. O. is based in Slovakia, with the head office in Bratislava. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on March 11, 2010. There was a net sales revenue increase of 230.53% reported in Essepharm S. R. O.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 143.34%. The net profit margin of Essepharm S. R. O. decreased by 0.15% in 2024.

Headquarters
Vysehradska, 12
Bratislava; Bratislavsky; Postal Code: 85106

Contact Details: Purchase the Essepharm S. R. O. report to view the information.

Basic Information
Registered Capital:
Purchase the Essepharm S. R. O. report to view the information.
Financial Auditors:
Purchase the Essepharm S. R. O. report to view the information.
Incorporation Date:
March 11, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Essepharm S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
230.53%
Total operating revenue
230.52%
Operating profit (EBIT)
120.96%
EBITDA
89.44%
Net Profit (Loss) for the Period
165.46%
Total assets
143.34%
Total equity
216.71%
Operating Profit Margin (ROS)
-0.48%
Net Profit Margin
-0.15%
Return on Equity (ROE)
-13.22%
Debt to Equity Ratio
-0.15%
Quick Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?